Clinical Trial Details
— Status: Withdrawn
Administrative data
NCT number |
NCT05169151 |
Other study ID # |
2020-1048 |
Secondary ID |
NCI-2021-1099420 |
Status |
Withdrawn |
Phase |
|
First received |
|
Last updated |
|
Start date |
February 17, 2022 |
Est. completion date |
April 18, 2023 |
Study information
Verified date |
April 2023 |
Source |
M.D. Anderson Cancer Center |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
This study attempts to learn more about the activity levels of adolescent and young adult
(AYA) cancer patients or survivors at risk for cardiovascular morbidity and frailty by using
a smartphone application called Beiwe. Collecting activity level data on AYA cancer patients
or survivors may help patients achieve better quality of life.
Description:
PRIMARY OBJECTIVES:
I. To characterize patient mobility over time based upon smartphone sensor data, including
dwell time at home and hospital, as well as time spent away from home or hospital,
considering patients actively undergoing treatment (time referenced to treatment start)
separately from those following treatment (time referenced to treatment end).
II. To characterize patient physical activity over time based upon smartphone sensor data,
during and following treatment (separately), including inactivity time and activity level, at
home and hospital and away from home or hospital, considering patients actively undergoing
treatment (time referenced to treatment start) separately from those following treatment
(time referenced to treatment end).
SECONDARY OBJECTIVES:
I. To characterize patient mobility over time based upon smartphone sensor data, including
dwell time at home and hospital, as well as time spent away from home or hospital,
considering patients actively undergoing treatment (time referenced to treatment start)
separately from those following treatment (time referenced to treatment end), grouped by
disease and treatment (chemotherapy, radiotherapy), controlling for age, sex, race, and body
mass index (BMI).
II. To characterize patient physical activity over time based upon smartphone sensor data
during and following treatment (separately), including inactivity time and activity level, at
home and hospital and away from home or hospital, considering patients actively undergoing
treatment (time referenced to treatment start) separately from those following treatment
(time referenced to treatment end), grouped by disease and treatment (chemotherapy,
radiotherapy), controlling for age, sex, race, and BMI.
OUTLINE:
Patients utilize smartphone application to monitor physical activity and mobility up to 180
days during treatment or post-treatment.